详情页 - 河北医科大学第四医院机构库

当前位置：首页 > 详情页

Effect of Huaier Granule on Adjuvant Treatment for High-risk Early-stage Triple-negative Breast Cancer

6| 链接全文 |

文献详情

编号/登记号：

注册时间：

研究开始时间：

研究结束时间：

项目类型：

本院角色：

多中心研究：

招募状态：

试验分期：

研究疾病/适应症：

研究类型：

研究负责人：

研究参与人：

研究单位： [1]Fudan University [2]The First Affiliated Hospital of USTC, Anhui Provincial Hospital Hefei, Anhui, China [3]Guangdong Provincial People's Hospital Guangzhou, Guangdong, China [4]The Fourth Hospital of Hebei Medical University, Hebei Tumor Hospital Shijia Zhuang, Hebei, China [5]The First Affiliates Hospital of Ha'erbin University Ha'erbin, Heilongjiang, China [6]Henan Provincial People's Hospital Zhengzhou, Henan, China [7]Tongji Medical College of HUST Wuhan, Hubei, China [8]Union Hospital Tongji Medical College Huazhong Univeristy of Science and Technology Wuhan, Hubei, China [9]Zhongnan Hospital of Wuhan University Wuhan, Hubei, China [10]Jiangsu Provincial Hospital Nanjing, Jiangsu, China [11]Nanjing Drum Tower Hospital, the Affiliated Hospital of Nanjing University Medical School Nanjing, Jiangsu, China [12]The First Affiliated Hospital of Soochow University Suzhou, Jiangsu, China [13]Northern Jiangsu People's Hospital Yangzhou, Jiangsu, China [14]Qilu Hospital of Shandong University Jinan, Shandong, China [15]LongHua Hospital Shanghai University of Traditional Chinese Medicine Shanghai, Shanghai, China [16]The Second Affiliated Hospital Zhejiang Univerisity of Medicine Hangzhou, Zhejiang, China [17]Huamei Hospital, University of Chinese Academy of Sciences Ningbo, Zhejiang, China [18]The First School of Medicine, School of Information and Engineering,the First Affiliated Hospital of WMU Wenzhou, Zhejiang, China [19]The First Affiliated Hospital of Anhui Medical University Hefei, Anhui, China

关键词： Huaier Granule Triple-negative Breast Cancer Invasive Ductal Carcinoma Breast Adjuvant Treatment

研究目的：

This is a prospective, multicenter, randomized, parallel controlled, open-label study. The primary purpose of this study is to evaluate the efficacy of Huaier Granule on postoperative adjuvant therapy of high-risk early-stage triple-negative invasive ductal carcinoma. The Secondary purposes are to evaluate the safety of long-term use of Huaier granules as postoperative adjuvant treatment of high-risk early-stage triple-negative invasive ductal carcinoma, and the changes of quality of life score after treatment with Huaier granule.